Skip to main content
Article
MISIPI study: Melanoma ImmunoScore evaluation in patients treated with IPIlimumab
Journal of Translational Medicine (2014)
  • Carlo Bifulco, Earle A. Chiles Research Institute – Providence Cancer Center, Portland, USA
  • Marilena Capone, Istituto Nazionale Tumori Fondazione “G. Pascale”, Napoli, Italy
  • Zip Feng, Earle A. Chiles Research Institute – Providence Cancer Center, Portland, USA
  • Gabriele Madonna, Istituto Nazionale Tumori Fondazione “G. Pascale”, Napoli, Italy
  • Ester Simeone, Istituto Nazionale Tumori Fondazione “G. Pascale”, Napoli, Italy
  • Marcello Curvietto, Istituto Nazionale Tumori Fondazione “G. Pascale”, Napoli, Italy
  • Nicola Mozzillo, Istituto Nazionale Tumori Fondazione “G. Pascale”, Napoli, Italy
  • Gennaro Ciliberto, Istituto Nazionale Tumori Fondazione “G. Pascale”, Napoli, Italy
  • Gerardo Botti, Istituto Nazionale Tumori Fondazione “G. Pascale”, Napoli, Italy
  • Bernard A Fox, Earle A. Chiles Research Institute – Providence Cancer Center, Portland, USA
  • Paolo A Ascierto, Istituto Nazionale Tumori Fondazione “G. Pascale”, Napoli, Italy
Publication Date
May 6, 2014
DOI
10.1186/1479-5876-12-S1-P11
Citation Information
Carlo Bifulco, Marilena Capone, Zip Feng, Gabriele Madonna, et al.. "MISIPI study: Melanoma ImmunoScore evaluation in patients treated with IPIlimumab" Journal of Translational Medicine Vol. 12 Iss. 1 (2014) p. 11
Available at: http://works.bepress.com/carlo-bifulco/114/